Tregs are demonstrated to enhance the progression of GBM via suppressing antitumor immunity and establishing an immunosuppressive environment.99 An increase in the number of Tregs in gliomas leads to the production of high levels of IL-10 and TGF-β91 (Fig. 3). The gene discussed is IL10; the disease is central nervous system cancer.